ViiV Healthcare; Gilead Sciences; Merck & Co. Inc.; Bristol-Myers Squibb Company; Janssen (Johnson&Johnson); F. HOFFMANN-LA ROCHE LTD; Boehringer Ingelheim (C.H. Boehringer Sohn AG & Ko. KG); AbbVie Inc.; GlaxoSmithKline plc; Mylan Pharmaceuticals; Pfizer; TEVA PHARMACEUTICAL INDUSTRIES LTD; Hetero Drugs; Daiichi Sankyo; Emcure; AstraZeneca; CIPLA; Alexion Pharmaceuticals; Shionogi; Theratechnologies; Abbott Laboratories Inc.